A new study led by Carla Finkielstein, an associate professor at the Fralin Biomedical Research Institute at VTC, and Diego Golombek, a professor at the National University of Quilmes, reveals that chronic jet lag impedes the body’s immune system and also changes the tumor microenvironment, favoring tumor growth.
Ian Kimbrough, an assistant professor in the School of Neuroscience, and Jennifer Munson, an assistant professor in the Department of Biomedical Engineering and Mechanics, are taking research learned from brain tumors to help fight Alzheimer’s.
Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer.
A diverse array of bacteria live in the human mouth as part of a vital ecosystem known as the oral microbiome. Virginia Tech researchers have discovered that one of these common bacteria can leave the mouth and potentially cause existing cancer cells in other parts of the body to spread.
Using a combination of experiments and mathematical modeling, a team of researchers from the Department of Biological Sciences and the Fralin Life Sciences Institute are beginning to unravel the mechanisms that lie behind tetraploidy - a chromosomal abnormality that is often found in malignant tumors.
Finkielstein, a molecular biologist and an associate professor in the College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1. Her laboratory, which studies how circadian rhythms are involved in breast cancer progression, will move to the Health Sciences and Technology Campus in Roanoke.
A team of researchers, including the veterinary college’s John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery, analyzed tumor samples from dozens of gliomas in adults, children, and dogs and uncovered a remarkable degree of similarity between pediatric and canine tumors.
Fox, director of the Center for Neurobiology Research at the Fralin Biomedical Research Institute at VTC, will move from his current leadership position into a new role as director of the School of Neuroscience, taking over a position held by founding director Harald Sontheimer.
The same brain cells designed to stop brain damage fail to support healthy neurons when a cancer grows. New research, led by Stefanie Robel and Harald Sontheimer at the Fralin Biomedical Research Institute at VTC, reveals how gliomas alter astrocytes, a cell type that helps protect neurons and is crucial to preventing seizures.
The inaugural Mitzi L. Frank Memorial Scholarship has been awarded to Jesse Janoski, a first-year graduate student in the Department of Biological Sciences, who is researching cancer and circadian rhythms.
Ophira Ginsburg, medical oncologist and executive director of the High-Risk Cancer Genetics Program at New York University’s Perlmutter Cancer Center, will discuss how social inequalities negatively impact cancer survival rates on Dec. 5 in Roanoke.
Colorectal cancer is the second most common form of cancer in the world, with rates about 30 percent higher in developed countries. It’s expected to cause 51,020 deaths in the United States during 2019.